$1.05 Billion is the total value of HARBOURVEST PARTNERS LLC's 51 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 533.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MNDY | New | Monday.com | $274,540,000 | – | 1,227,874 | +100.0% | 26.24% | – |
BHG | New | Bright Health Group, Inc. | $72,376,000 | – | 4,217,715 | +100.0% | 6.92% | – |
FTCH | New | Farfetch Ltd.ordinary shares cla | $22,295,000 | – | 442,716 | +100.0% | 2.13% | – |
WHD | New | Cactus, Inc. | $14,427,000 | – | 392,896 | +100.0% | 1.38% | – |
DELL | New | Dell, Inc. | $6,703,000 | – | 67,253 | +100.0% | 0.64% | – |
CVRX | New | CVRx, Inc. | $5,977,000 | – | 213,479 | +100.0% | 0.57% | – |
UPST | New | Upstart Holdings, Inc. | $5,652,000 | – | 45,251 | +100.0% | 0.54% | – |
ZUO | Buy | Zuora, Inc. | $5,158,000 | +112.6% | 299,032 | +82.5% | 0.49% | +51.7% |
PGNY | New | Progyny, Inc. | $2,799,000 | – | 47,441 | +100.0% | 0.27% | – |
TENB | New | Tenable Holdings, Inc. | $2,275,000 | – | 55,029 | +100.0% | 0.22% | – |
ROOT | New | Root, Inc. | $2,211,000 | – | 204,314 | +100.0% | 0.21% | – |
PATH | New | UiPath, Inc. | $2,162,000 | – | 31,830 | +100.0% | 0.21% | – |
ABCL | New | AbCellera Biologics, Inc. | $1,302,000 | – | 59,200 | +100.0% | 0.12% | – |
NRIX | New | Nurix Therapeutics, Inc. | $1,171,000 | – | 44,141 | +100.0% | 0.11% | – |
ACVA | New | ACV Auctions, Inc. | $1,026,000 | – | 40,049 | +100.0% | 0.10% | – |
RPTX | Buy | Repare Therapeutics, Inc. | $460,000 | +22.0% | 14,747 | +20.1% | 0.04% | -13.7% |
ALGS | New | Aligos Therapeutics, Inc. | $383,000 | – | 18,783 | +100.0% | 0.04% | – |
JNCE | Buy | Jounce Therapeutics, Inc. | $362,000 | +76.6% | 53,260 | +167.3% | 0.04% | +29.6% |
BILL | New | Bill.com Holdings, Inc. | $324,000 | – | 1,770 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Wayfair, Inc. | 25 | Q3 2023 | 83.5% |
Trevena, Inc. | 25 | Q4 2021 | 1.2% |
Finjan Holdings, Inc. | 23 | Q2 2020 | 18.5% |
Zuora, Inc. | 21 | Q3 2023 | 3.4% |
Evelo Biosciences, Inc. | 20 | Q1 2023 | 26.3% |
CytomX Therpeutics, Inc. | 19 | Q4 2021 | 2.3% |
LendingClub Corp. | 18 | Q3 2019 | 11.9% |
Rubius Therapeutics, Inc. | 18 | Q4 2022 | 21.4% |
Solarwinds Corp. | 17 | Q4 2022 | 60.4% |
Axcella Health, Inc. | 17 | Q2 2023 | 6.7% |
View HARBOURVEST PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SolarWinds Corp | February 14, 2022 | 3,719,600 | 2.3% |
N-able, Inc. | December 20, 2021 | 3,719,600 | 2.1% |
OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,901,106 | 4.9% |
Wayfair Inc. | February 16, 2016 | 2,115,296 | 4.6% |
ENVIVIO INC | February 13, 2013 | 3,639,939 | 13.5% |
NETWORK ENGINES INCSold out | February 13, 2013 | 0 | 0.0% |
VOCALTEC COMMUNICATIONS LTD | August 06, 2010 | 243,689 | 2.1% |
CERAGON NETWORKS LTDSold out | July 26, 2007 | 0 | 0.0% |
VISTAPRINT LTDSold out | February 14, 2007 | 0 | 0.0% |
VOCALTEC COMMUNICATIONS LTD | May 26, 2006 | 1,218,444 | 24.4% |
View HARBOURVEST PARTNERS LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
40-APP | 2024-04-24 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR/A | 2022-05-26 |
View HARBOURVEST PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.